Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial

INTRODUCTION: Fluticasone furoate (FF)/vilanterol (VI) dry powder inhaler (DPI) is the only once-daily maintenance inhaled corticosteroid (ICS)/long-acting β2 adrenergic agonist (LABA) combination for asthma. We aimed to compare the clinical effects of once-daily FF/VI and twice-daily budesonide (BU...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuhashi, Kazuki, Fujisawa, Tomoyuki, Hashimoto, Dai, Kamiya, Yousuke, Yasui, Hideki, Karayama, Masato, Suzuki, Yuzo, Hozumi, Hironao, Enomoto, Noriyuki, Nakamura, Yutaro, Inui, Naoki, Suda, Takafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756272/
https://www.ncbi.nlm.nih.gov/pubmed/31571932
http://dx.doi.org/10.2147/JAA.S223093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756272/
https://www.ncbi.nlm.nih.gov/pubmed/31571932
http://dx.doi.org/10.2147/JAA.S223093

Ejemplares similares